Cibus, Inc. (CBUS) vs LENZ Therapeutics, Inc. (LENZ)
A side-by-side comparison of Cibus, Inc. and LENZ Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CBUS
Cibus, Inc.
$1.57HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
LENZ
LENZ Therapeutics, Inc.
$3.79HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CBUS vs LENZ
growth of $100 · dividends reinvested · last 5yCBUS -99.2% (-61.6%/yr)LENZ -91.4% (-38.7%/yr)LENZ compounded faster over this window
Log scale — wide-divergence pair
CBUS LENZ
CBUS vs LENZ: by the numbers
- •CBUS is the larger company ($120M vs $119M market cap).
- •Both run net losses; LENZ's is the smaller (-586.74% vs -2258.89% net margin).
Metrics side by side
Valuation
| Metric | CBUS | LENZ |
|---|---|---|
| P/S ratio | 27.57 | 5.53 |
| P/B ratio | 8.10 | 0.54 |
Profitability
| Metric | CBUS | LENZ |
|---|---|---|
| Gross margin | -62.76% | 90.14% |
| Operating margin | -1853.92% | -477.46% |
| Net margin | -2258.89% | -586.74% |
| ROE | -663.38% | -57.47% |
| ROIC | -17.99% | -61.84% |
Growth (annualized)
| Metric | CBUS | LENZ |
|---|---|---|
| Revenue CAGR (5Y) | -34.28% | N/A |
| Total return CAGR (5Y) | -59.70% | -35.49% |
Frequently asked
- How have CBUS and LENZ total returns compared?
- Over the past 5 years, CBUS delivered -59.70% and LENZ delivered -35.49% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.